A faster, simpler path to treatment for patients
When patients run into coverage concerns and treatment delays, they may be unable to access the medications they've been prescribed. By sharing trusted benefit intelligence, we can help pharmaceutical and biotech companies get innovative therapies to patients sooner.
Help patients navigate their benefit coverage.
Give your team more power to help patients overcome the financial barriers that can hinder treatment.
1 in 5 insured U.S. patients say they have trouble navigating, understanding and anticipating their health insurance.1
43.1 million patients in the U.S. had more than one type of health insurance coverage in 2021.2
Get patients started on medication sooner.
Avoid delays caused by phone calls, faxes and inefficient systems.
Missing information and manual processes can stretch patient time to specialty therapy to seven weeks.3
Solutions
Improve patient access & time to therapy
Overcome patient access challenges with timely benefit insights that get patients started on treatment sooner.
Intelligent Prior Authorization
Anticipate and overcome prior authorization barriers to accelerate determinations for your therapies.
A powerful partnership
A single, direct connection to health plans and PBMs nationwide
Optimize speed and efficiency with accurate data from health plans and PBMs.
Read more
Read less
Leading speed and reliability
Surescripts delivers transactions in milliseconds across a network with a 99.995% average uptime.4
Read more
Read less
Vast network
The Surescripts Master Patient Index includes data for virtually every insured American.5
Read more
Read less
Find out more about Life sciences companies
What does Surescripts offer life sciences companies?
Surescripts integrates tools, data and insights for life sciences companies to inform and accelerate decisions, including timely benefit data, streamlined prior authorization workflows and prescription-level intelligence.
Who are Surescripts’ life sciences solutions built for?
Surescripts solutions are built for life sciences companies looking to support patient access, speed time to therapy, reduce therapy abandonment and improve commercial success.
How is Surescripts’ approach different from simply digitizing prior authorization?
Surescripts solutions automate prior authorization by combining clinical insights and benefit intelligence, rather than just converting manual work into electronic forms.
Keep pace with healthcare innovation
- PhRMA, “Patient Experience Survey — Navigating the Patient Experience: The Barriers and Burdens Standing Between Patients and Care,” September 11, 2022.
- Laryssa Mykyta et al., “About 43 Million People in the U.S. Had Multiple Health Plans in 2021,” Census.gov, July 19, 2023.
- AssistRx, “The Intelligent Way to Initiate and Advance Specialty Therapies,” presented at Surescripts Specialty Medication Symposium, March 25, 2021.
- Surescripts, “2024 Annual Impact Report,” March 2025, p.5.
- Surescripts, “2024 Annual Impact Report,” p.5.
Dean Riggott Photography
Surescripts